H. Ehrlinder

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

A. Gąsecka, D. Bongiovanni, W. Parker, 2021, European journal of preventive cardiology.

Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death

N. Orsini, B. Gigante, K. Modig, 2022, Research and practice in thrombosis and haemostasis.

Clinical characteristics and antithrombotic prescription in elderly hospitalized atrial fibrillation patients

N. Orsini, B. Gigante, K. Modig, 2020, International journal of cardiology. Heart & vasculature.

Blood coagulation disorders in heart failure: from basic science to clinical perspectives.

A. Gąsecka, D. Bongiovanni, R. Guerreiro, 2023, Journal of cardiac failure.

Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment.

A. Gąsecka, D. Bongiovanni, R. Guerreiro, 2021, Blood reviews.

Is the association of QTc with atrial fibrillation and stroke in cohort studies a matter of time?

J. Engdahl, B. Gigante, K. Leander, 2022, Open Heart.

Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction.

A. Gąsecka, H. Ehrlinder, J. Borovac, 2023, Current problems in cardiology.